These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18173614)

  • 1. Extensive hypopigmentation after starting antiretroviral treatment in an human immunodeficiency virus (HIV)-seropositive African woman.
    Kigonya C; Lutwama F; Colebunders R
    Int J Dermatol; 2008 Jan; 47(1):102-3. PubMed ID: 18173614
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.
    Rey D; L'Héritier A; Lang JM
    Clin Infect Dis; 2002 Feb; 34(3):418-9. PubMed ID: 11774091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical safety of a generic fixed-dose combination of stavudine/lamivudine/névirapine (Triomune). Study of 297 cases in Togo].
    Mouhari-Touré A; Saka B; Kombat K; Tchangaï-Walla K; Pitche P
    Bull Soc Pathol Exot; 2008 Dec; 101(5):404-6. PubMed ID: 19192611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dandy-Walker variant in an infant prenatally exposed to antiretroviral medication.
    Urban MF; Chersich MF
    S Afr Med J; 2007 Oct; 97(10):947-8. PubMed ID: 18000575
    [No Abstract]   [Full Text] [Related]  

  • 6. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
    Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
    AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic, socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in northern Thailand.
    Tsuchiya N; Pathipvanich P; Yasuda T; Mukoyama Y; Rojanawiwat A; Matsubayashi T; Saeng-aroon S; Auwanit W; Matsuyama A; Sawanpanyalert P; Ariyoshi K
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):71-82. PubMed ID: 19323037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy.
    Jongwutiwes U; Malathum K; Sungkanuparph S
    J Med Assoc Thai; 2007 Nov; 90 Suppl 2():85-8. PubMed ID: 19230429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed human immunodeficiency virus after sepsis-like reaction of trimethoprim-sulfamethoxazole.
    Moran KA; Ales NC; Hemmer PA
    South Med J; 2001 Mar; 94(3):350-2. PubMed ID: 11284528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stavudine and lamivudine. Two new nucleoside analogues efficient against HIV].
    Gerstoft J
    Ugeskr Laeger; 1998 Jan; 160(4):457-61. PubMed ID: 9463266
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple antiretroviral therapy improves psoriasis associated with human immunodeficiency virus infection: a clinico-therapeutic experience.
    Mahajan VK; Sharma NL; Sarin S; Bansal A; Sud N
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1017-8. PubMed ID: 18070027
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO; Olatunji PO; Salami AK; Odeigah L; Iseniyi JO
    Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting lactic acidosis in an HIV-1 infected pregnant woman on antiretroviral therapy.
    Mendes N; Aboím L; Borges A; Guerreiro C; Castelo-Branco C
    J Obstet Gynaecol; 2013 Apr; 33(3):310-2. PubMed ID: 23550869
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral adverse effects due to the use of Nevirapine.
    Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
    J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Saekang N; Pairoj W; Chantratita W
    J Clin Virol; 2008 Apr; 41(4):310-3. PubMed ID: 18316243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous skin eruption in an HIV patient during antiretroviral drugs therapy.
    Atzori L; Pinna AL; Pilloni L; Ferreli C; Pau M; Aste N
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S30-4. PubMed ID: 18837731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.